These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 12387700)

  • 61. Efficacy of Cannabinoids in a Pre-Clinical Drug-Screening Platform for Alzheimer's Disease.
    Schubert D; Kepchia D; Liang Z; Dargusch R; Goldberg J; Maher P
    Mol Neurobiol; 2019 Nov; 56(11):7719-7730. PubMed ID: 31104297
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The Therapeutic Potential of Cannabis in Counteracting Oxidative Stress and Inflammation.
    Graczyk M; Lewandowska AA; Dzierżanowski T
    Molecules; 2021 Jul; 26(15):. PubMed ID: 34361704
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Neuroscience. Stout guards of the central nervous system.
    Mechoulam R; Lichtman AH
    Science; 2003 Oct; 302(5642):65-7. PubMed ID: 14526067
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Therapeutic use of cannabinoids in neurology].
    Schwenkreis P; Tegenthoff M
    Schmerz; 2003 Oct; 17(5):367-73. PubMed ID: 14513344
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cannabinoid system and neuroinflammation: implications for multiple sclerosis.
    Correa F; Docagne F; Mestre L; Loría F; Hernangómez M; Borrell J; Guaza C
    Neuroimmunomodulation; 2007; 14(3-4):182-7. PubMed ID: 18073512
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cannabinoid analgesia.
    Walker JM; Huang SM
    Pharmacol Ther; 2002 Aug; 95(2):127-35. PubMed ID: 12182960
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cannabinoid receptors and their ligands.
    Pertwee RG; Ross RA
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):101-21. PubMed ID: 12052030
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cannabinoids: a real prospect for pain relief?
    Iversen L; Chapman V
    Curr Opin Pharmacol; 2002 Feb; 2(1):50-5. PubMed ID: 11786308
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Cannabinoids in multiple sclerosis -- therapeutically reasonable?].
    Trebst C; Stangel M
    Fortschr Neurol Psychiatr; 2005 Aug; 73(8):463-9. PubMed ID: 16052440
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The Use of Compounds Derived from
    Stasiłowicz-Krzemień A; Nogalska W; Maszewska Z; Maleszka M; Dobroń M; Szary A; Kępa A; Żarowski M; Hojan K; Lukowicz M; Cielecka-Piontek J
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891938
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cannabinoids and neuroprotection in CNS inflammatory disease.
    Jackson SJ; Diemel LT; Pryce G; Baker D
    J Neurol Sci; 2005 Jun; 233(1-2):21-5. PubMed ID: 15894331
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Neuroprotective antioxidants from marijuana.
    Hampson AJ; Grimaldi M; Lolic M; Wink D; Rosenthal R; Axelrod J
    Ann N Y Acad Sci; 2000; 899():274-82. PubMed ID: 10863546
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Dexanabinol: a novel cannabinoid with neuroprotective properties.
    Darlington CL
    IDrugs; 2003 Oct; 6(10):976-9. PubMed ID: 14534855
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset.
    Shoemaker JL; Seely KA; Reed RL; Crow JP; Prather PL
    J Neurochem; 2007 Apr; 101(1):87-98. PubMed ID: 17241118
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cannabis and the brain.
    Iversen L
    Brain; 2003 Jun; 126(Pt 6):1252-70. PubMed ID: 12764049
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cannabinoids in the treatment of pain and spasticity in multiple sclerosis.
    Smith PF
    Curr Opin Investig Drugs; 2002 Jun; 3(6):859-64. PubMed ID: 12137404
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The neurobiology of erythropoietin.
    Sytkowski AJ
    Cell Mol Neurobiol; 2011 Aug; 31(6):931-7. PubMed ID: 21538117
    [No Abstract]   [Full Text] [Related]  

  • 78. Assessment of cannabinoid induced gene changes: tolerance and neuroprotection.
    Grigorenko E; Kittler J; Clayton C; Wallace D; Zhuang S; Bridges D; Bundey S; Boon A; Pagget C; Hayashizaki S; Lowe G; Hampson R; Deadwyler S
    Chem Phys Lipids; 2002 Dec; 121(1-2):257-66. PubMed ID: 12505705
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pharmacokinetics and pharmacodynamics of cannabinoids.
    Grotenhermen F
    Clin Pharmacokinet; 2003; 42(4):327-60. PubMed ID: 12648025
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Identification of the endogenous cannabinoid system through integrative pharmacological approaches.
    Martin BR
    J Pharmacol Exp Ther; 2002 Jun; 301(3):790-6. PubMed ID: 12023505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.